Literature DB >> 3516154

Comparative studies of total cross-linking, cell survival and cell cycle perturbations in Chinese hamster cells treated with alkylating agents in vitro.

B C Millar, M J Tilby, M G Ormerod, A W Payne, S Jinks, P S Loverock.   

Abstract

The toxicities of 4-hydroperoxycyclophosphamide (4-OOH CY), phosphoramide mustard (PM), melphalan (MEL) and busulphan (BU) have been compared in Chinese hamster cells, V-79-753B. The initial total amount of cross-linking was a determining factor for the clonogenic survival of cells treated with MEL or PM. Although 4-OOH CY generated cross-links in this cell line, this damage did not account for the toxicity of the compound. There was no evidence for cross-link formation in cells treated with BU, even at a dose of the drug (1000 micrograms/ml) that was too toxic to measure clonogenic survival. Comparison for the four compounds at equitoxic doses showed that both PM and MEL caused the arrest of the cell cycle at G2 which persisted after drug removal. This was accompanied by a decline in the population growth rate and a decrease in total cell count. In contrast, both BU and 4-OOH CY caused a temporary arrest of the cell cycle G2, 24 hr after drug removal. However, the cell cycle distribution returned the control values within 3-4 days after treatment. Both BU and 4-OOH CY showed little effect on the initial growth rate of the cells. It is concluded that the initial amount of cross-links contributes to the toxicity of PM and MEL. However, it is unlikely that the generation of cross-links is of major importance for the toxicity of either 4-OOH CY or BU.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3516154     DOI: 10.1016/0006-2952(86)90155-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  4 in total

1.  Overexpression of glutathione S-transferase A1-1 in ECV 304 cells protects against busulfan mediated G2-arrest and induces tissue factor expression.

Authors:  Christoph A Ritter; Bernhard Sperker; Markus Grube; Dana Dressel; Christiane Kunert-Keil; Heyo K Kroemer
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

2.  An efficient multiple-exposure analysis of the toxicity of crisnatol, a DNA intercalator in phase II clinical trials.

Authors:  R M Zucker; D J Adams; K W Bair; K H Elstein
Journal:  Invest New Drugs       Date:  1992-04       Impact factor: 3.850

3.  Altered gene expression in busulfan-resistant human myeloid leukemia.

Authors:  Benigno C Valdez; David Murray; Latha Ramdas; Marcos de Lima; Roy Jones; Steven Kornblau; Daniel Betancourt; Yang Li; Richard E Champlin; Borje S Andersson
Journal:  Leuk Res       Date:  2008-03-12       Impact factor: 3.156

4.  Increasing the effective concentration of melphalan in experimental rat liver tumours: comparison of isolated liver perfusion and hepatic artery infusion.

Authors:  A Marinelli; J H van Dierendonck; G M van Brakel; H Irth; P J Kuppen; U R Tjaden; C J van de Velde
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.